Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study

被引:0
|
作者
Arrospide, A. [1 ,2 ]
Sagardui, M. G. [1 ]
Larizgoitia, I. [1 ]
Iturralde, A. [1 ,3 ]
Moreda, A. [1 ]
Mar, J. [2 ,4 ,5 ]
机构
[1] Minist Hlth Basque Govt, Donostia San Sebastian Kalea 1, Vitoria 01010, Spain
[2] Biodonostia Hlth Res Inst, Econ Evaluat Chron Dis Res Grp, San Sebastian, Spain
[3] Osakidetza Basque Hlth Serv, Directorate Gen, Vitoria, Spain
[4] Debagoiena Integrated Hlth Org, Osakidetza Basque Hlth Serv, Arrasate Mondragon, Spain
[5] Kronikgune Inst Hlth Serv Res, Baracaldo, Spain
关键词
COVID-19; Vaccine; Vaccine booster; Effectiveness; Hospital admissions; Omicron; IMPACT;
D O I
10.1016/j.vaccine.2023.05.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of the study was to assess the effect of a booster dose of COVID-19 vaccine on the rates of hospital ward and intensive care unit (ICU) admissions around the time of emergence of the Omicron variant in the Basque Country. A retrospective cohort population-based study was conducted. The population with any records related to COVID-19 vaccination up to 28 February 2022 was classified into four cohorts by vaccination status. For every cohort, the hospital ward and ICU admission rates were calculated for each day between November 2021 and February 2022. Generalized linear models with a negative binomial distribution were used to estimate the age-adjusted hospitalization rate ratio of the cohort of individuals who had received a booster compared to the other cohorts. The age-adjusted rates of hospital ward and ICU admissions were 70.4 % and 72.0 % lower, respectively, in the fully vaccinated plus booster group compared to the fully vaccinated but no booster group. Analysing changes in the 14-day admission incidence rates showed that as the prevalence of the Omicron variant increased, the corresponding rate ratios decreased. The immunity acquired with the booster dose allowed the hospital network to meet all the demand for hospitalization during a period of high incidence of COVID-19, despite the fact that vaccine protection decreased as the prevalence of the Omicron variant increased. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4274 / 4279
页数:6
相关论文
共 50 条
  • [1] Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study
    Arbel, Ronen
    Peretz, Alon
    Sergienko, Ruslan
    Friger, Michael
    Beckenstein, Tanya
    Duskin-Bitan, Hadar
    Yaron, Shlomit
    Hammerman, Ariel
    Bilenko, Natalya
    Netzer, Doron
    LANCET INFECTIOUS DISEASES, 2023, 23 (08): : 914 - 921
  • [2] Evaluation of COVID-19 Booster Vaccine Effectiveness
    Qu, Bingqian
    Zhang, Dingmei
    VIRUSES-BASEL, 2025, 17 (02):
  • [3] Why promoting a COVID-19 vaccine booster dose?
    Loubet, Paul
    Laureillard, Didier
    Martin, Aurelie
    Larcher, Romaric
    Sotto, Albert
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2021, 40 (06)
  • [4] Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
    Jia, Siyue
    Yin, Zundong
    Pan, Hongxing
    Wang, Fuzhen
    Liu, Xiaoqiang
    Wang, Qing
    Zhang, Li
    Tang, Jihai
    Yang, Hao
    Du, Jiangbo
    Wang, Zhiguo
    Jin, Pengfei
    Peng, Zhihang
    Tang, Rong
    Kang, Guodong
    Wang, Xuewen
    Li, Simin
    Wang, Weixiao
    Li, Jingxin
    Shen, Hongbing
    Zhu, Fengcai
    EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [5] mRNA Booster Improves a COVID-19 Vaccine's Effectiveness
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (18): : 1749 - 1749
  • [6] Prurigo pigmentosa following booster dose of COVID-19 vaccine
    Skowron, Francois
    Carbonnelle-Puscian, Amelie
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E289 - E290
  • [7] Importance of the COVID-19 Vaccine Booster Dose in Protection and Immunity
    Abdollahi, Alireza
    Afsharyzad, Yeganeh
    Vaezi, Atefeh
    Meysamie, Alipasha
    VACCINES, 2022, 10 (10)
  • [8] Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
    Mattiuzzi, Camilla
    Lippi, Giuseppe
    VACCINES, 2023, 11 (02)
  • [9] The pros and cons of the second booster dose of the COVID-19 vaccine
    Mostafavi, Ehsan
    IRANIAN JOURNAL OF MICROBIOLOGY, 2022, 14 (04) : 435 - 437
  • [10] Assessing the acceptability of COVID-19 vaccine and its booster dose
    Mubarak, Sawsan
    A'aqoulah, Ashraf
    AlGhawrie, Hadeel
    Albalas, Samir
    Innab, Nisreen
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (09)